Description
AI-Powered small molecule discovery and drug repurposing
DrugForge accelerates the development of new drugs for your validated targets by combining traditional molecular docking with AI-driven simulation.
Here’s how DrugForge works:
- Docking at scale: Screen millions of small molecules against protein structures from PDB, AlphaFold, or ab initio predictions.
- AI-powered simulations: Predict pharmacodynamics and kinetics to prioritize candidates for experimental validation.
- Combinatorial strategies: Identify synergistic drug combinations for maximal biological impact.
- Efficacy optimization: Use ML models to refine drug performance by analyzing multi-omic pathways and molecular processes.
DrugForge transforms drug discovery from a slow, trial-and-error process into a data-driven, precision-engineered pipeline.
